🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Denmark / NCT04685239
Starting soon Not applicable

Dual Mobility Cup Versus Unipolar Cup

NCT04685239 · tracked via the Priya Life Science Denmark tracker
Sponsor
Northern Orthopaedic Division, Denmark
Phase
Not applicable
Started
2023-04-01
Last updated
2023-03-27

Condition(s) studied

Dislocation, Hip

Investigational drug(s) / intervention(s)

dual mobility cupunipolar cup

dual mobility cup: The use of a Sunfit dual mobility cup

unipolar cup: The use of a TMT cup

Study summary

The general purpose of this study is to examine whether the dual mobility cup (Novae® Serf) reduces the number of hip dislocations after total hip replacement, both early dislocation (≤1 year) and late dislocation (\>1 year) after primary THR compared with a conventional cup design (Trabecular MetalTM Modular Acetabular System).

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with hip arthritis who are amenable to surgery with THR and age ≥ 65 years referred to the Department of Orthopedic Surgery at either Section Farsø, Frederikshavn Hospital or Aalborg University Hospital. Patients who are willing to participate in the trial and who give their written, informed consent after receiving oral and written information. Exclusion Criteria: * Patients who do not wish to participate. * Sequelae of Calvé-Legg-Perthes' disease, caput necrosis, epiphysiolysis. * Proximal femoral or acetabular fracture. * Hip dysplasia with subluxation Crowe types III and IV. * Earlier hip bone surgery (excluding arthroscopic surgery). * Elective bilateral surgery. * If the patient's bone morphology is unsuitable for a cemented Exeter® femoral stem. * Patients with no e-mail.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Aalborg University Hospital Aalborg Northen Denmark

More Northern Orthopaedic Division, Denmark trials in Denmark

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04685239 on ClinicalTrials.gov ↗ ← All trials in Denmark